Cancer

Starton Therapeutics to Present at Biotech Showcase 2026

Company Will Also Host 1x1 Investor Meetings at the 15th Annual LifeSci Partners Corporate Access Event from January 13-14th in…

7 days ago

Starton Therapeutics to Present at Biotech Showcase 2026

Company Will Also Host 1x1 Investor Meetings at the 15th Annual LifeSci Partners Corporate Access Event from January 13-14th in…

7 days ago

Mayo Clinic Jacksonville Comes Online as Third Site in Breathe BioMedical’s Ongoing Multi-Center Clinical Study to Develop a Breath Test for Early Detection of Breast Cancer in Females with Dense Breasts

Moncton, New Brunswick and Cambridge, Massachusetts--(Newsfile Corp. - December 16, 2025) - Breathe BioMedical, a company developing a breath analytics…

7 days ago

Detect-ION Launches Collaborative Project to Develop Breath-Based Diagnostics for Pneumonia-Causing Pathogens

TAMPA, Fla., Dec. 15, 2025 /PRNewswire/ -- Detect-ION, LLC, a health-tech startup based in Tampa, FL, today announced a collaborative…

1 week ago

Helio Genomics Forms Strategic Partnership with LiverRight Aimed at Broadening Nationwide Access to Early Liver Cancer Detection

Combining breakthrough blood-based test with same-week access to board-certified hepatologists in all 50 statesIRVINE, Calif., Dec. 15, 2025 /PRNewswire/ --…

1 week ago

Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Translational Oncology Research

Collaboration to leverage Lunit SCOPE IO ® and SCOPE universal IHC® (uIHC) digital pathology products in two Daiichi Sankyo oncology…

1 week ago

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s mNEXSPIKE (COVID-19 Vaccine, mRNA)

mNEXSPIKE is Moderna's third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and mRESVIA (Respiratory Syncytial…

1 week ago

Amphastar Announces FDA Approval for Teriparatide Injection

RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food…

1 week ago

InnoCare Announces Achievement of Primary Endpoint in Phase IIb Study of Orelabrutinib for SLE and Approval of Phase III Clinical Trial

BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the…

1 week ago